Mixture toxicity is a topic that has become a matter of concern during the last two decades. One of the major problems with assessing the toxicity of mixtures and the associated human and environmental risk is the large number of possible mixtures, as well as the fact that the actual mixture effect for a given set of constituents might strongly depend on the actual composition of the mixture, i.e., the ratios of the constituent, as well as their nature. This paper presents a possible approach to describe and thereby better understand the pharmacokinetics and dynamics of complex mixtures by combining quantitative structure-activity relationships to predict needed parameters, lumping to reduce the complexity of the problem, and physiologically based pharmacokinetic/pharmacodynamic modeling to integrate all this information into a complete toxicological description of the mixture. It is our hope that by presenting this conceptual approach we might be able to stimulate some criticisms and discussions in the toxicology community regarding this complex and yet very important area of research.
Introduction
Traditionally, both human and environmental toxicologists have studied the toxic effects (both lethal and sublethal, acute and chronic) of single substances. For decades, the most important toxicological parameter of a compound, and the one that increasingly should at least be determined, was the so-called LD50, or median lethal dose, for mammals and other terrestrial animal species or the LC50, or median lethal aqueous concentration, for aquatic species (including fish, crustaceans, and algae). As the science of toxicology advances, more and more complicated testing methods are developed and utilized, some of which can be extremely animal and resource intensive.
Over the last twenty years or so, however, it has become apparent that conventional toxicologic methodologies are neither practical for nor capable of assessing the toxicity of the huge number of single chemicals, particularly the almost infinite number of chemical mixtures. Thus, protecting both human and environmental health based on conventional toxicity testing may not be achievable. There are two major reasons for this problem.
First, there simply are too many different chemicals to be adequately tested for the large number of recognized or still unknown effects, especially on environmental health, which requires measurements of effect concentrations not only on single species but also on complex biotic communities or ecosystems. For example, the European Inventory of Existing Commercial Chemical Substances (EINECS) contains 100,000 individual entries (these are chemical products that are actually being marketed (1) ; the Chemical Abstracts Registry contains several million substances that have been (tentatively) synthesized in laboratories (2) ; and the Aquatic Toxicity Information Retrieval Database (AQUIRE) created and maintained by the U.S. EPA (3), the most comprehensive and reliable source of aquatic toxicity data, contains pertinent experimental data for about 5500 different chemicals.
Second, in real-life situations, humans and the environment normally are not exposed to single toxicants but to complex mixtures of large numbers of potentially hazardous and potentially interacting agents. Some brief examples illustrate this point. First, consider some of the recent thinking about the Persian Gulf War syndrome. It is now hypothesized that the causative agent for some reported illnesses might have been a combination of immunization shots, antinerve-gas prophylactics, insecticides, and insect repellents, all of which most Gulf War veterans were expected to apply before active duty (4, 5) . Alternatively, consider the major die-off of harbor seals reported in the Dutch and German section of the Wadden Sea several years ago. The cause of the dieoff, which originally stumped marine mammal researchers, finally appeared to be a combination of a normally innocuous mammalian virus infection and the immune system dysregulating effect of a high level of a complex mixture of organochlorine compounds, notably polychlorinated biphenyls (PCBs), followed by opportunistic infections (6, 7) . Last, current understanding of the potential of persistent chlorinated xenobiotics (such as PCBs, dieldrin, and toxaphene) to act as environmental estrogens also indudes a strongly synergistic mixture effect (8) .
It has been recognized for some time that one of the more promising approaches Environmental Health Perspectives * Vol 105, Supplement I * February 1997 m to dealing with the first problem, that of the existence of too many compounds to test for toxic effects, is the discipline known as predictive toxicology. This is a discipline that tries to predict the biological effects, including but not limited to acute toxicity, of chemicals from considerations of compound structure and knowledge about the target biological systems and subsystems. Two tools predictive toxicology has developed over the years are quantitative structure-activity relationships (QSAR) and physiologically based pharmacokinetic/ pharmacodynamic (PBPK/PD) modeling.
QSAR attempts to predict the qualitative structure-activity (SAR) or quantitative QSAR effect of a compound by analogy with a number of similar compounds (9) . SARs generally define a common substructure or overall shape similarity between compounds with similar modes of toxic action, using the presence or absence of this substructure in an unknown compound or the similarity of the unknown to the known active compounds to predict the likelihood of the unknown of exhibiting the same toxicity. QSARs attempt to identify quantitative structural parameters that correlate with the actual effect dose or concentration that elicits a common effect level (for example, LD50 or LC50).
PBPK/PD modeling approaches the issue of predicting biological effects not from the viewpoint of a chemical but from the viewpoint of a biological system. Basically, what a PBPK model does is to describe an organism (or a tissue or a cell) as a connected system of compartments in which mass balances, including transport processes, diffusion exchanges, metabolic and eliminatory clearances, receptor binding, etc., account for the uptake and disposition of chemicals in this organism (10) . If the PBPK model is verified against experimental data, the pharmacokinetics of the compound can be predicted by the model. This leads to two predictive improvements. First, most of the chemical-specific parameters (blood-tissue and tissue-tissue partition coefficients as well as metabolic and elimination rate constants) for an unknown can be determined in vitro and then used to create a predictive model. Second, if the biological specifics of an unknown target organism are available, a model can be adapted to predict the kinetics of a given chemical of interest for this unknown species. Furthermore, if for a specifically acting compound the pharmacodynamics at the target organ or site (e.g., a cell or enzyme) are known, these can be linked to the predicted pharmacokinetics and the complete PBPK/PD model can be employed to predict effect levels for a certain toxic effect. It has even been shown recently that it is possible to incorporate the biological variability found in nonclonal populations of a species into a PBPK/PD model for predictive toxicology by using Monte Carlo simulation techniques (11, 12) .
We describe here an integrated predictive toxicology approach that uses QSAR, PBPK/PD, and lumping analysis techniques to model the toxicologic effects of complex mixtures of chemicals. This approach is based on the concept that PBPK/PD modeling not only can predict the pharmacokinetics and dynamics of single compounds but is in principle also technically capable of incorporating the kinetics of a number of compounds simultaneously. Moreover, if the pharmacodynamics of these compounds are known (from in vitro studies or from studies with other species) and their possible interactions with each other have been studied, the overall toxic effect level of any dose or ratio of the mixture can, in principle, be predicted. QSAR (13) . Lumping can be used to treat compounds with the same or similar partition coefficients as a single surrogate compounds or to treat a set of agonists on a target organ, cell, or enzyme as a single agent with an average affinity or turnover rate.
All three techniques mentioned above will be described in more detail in another section of this paper as will ways in which these techniques might be combined into a comprehensive predictive toxicological approach. These techniques will be illustrated wherever possible by examples using such complex mixtures as JP-5, automotive gasoline, and other petroleum products. Finally, an example will be given of a tentative application of all three techniques to the toxicological modeling ofJP-5 exposure.
PBPK/PD Modeling
The uptake and disposition of chemicals (drugs and pharmaceuticals) by living organisms, most notably humans, long has been one of the primary concerns of pharmacological research. The study of the dispersion of chemicals in animal bodies constitutes the field of pharmacokineticsalthough, depending on the type of chemical studied, it has also been called toxicokinetics and biokinetics. For drug research, two parameters of the disposition of a drug are of special interest, namely the residence time of a compound in the body (most often reported as its half-life) and the (peak or average or both) target concentrationthe amount of the drug that actually reaches the pharmacodynamic target site and is thus in principle available for therapeutic (inter)action. Because of the limited *Bear in mind that all these modeling approaches, especially the PBPK paradigm, which relies heavily on the numerical solution (approximation) of sets of dependent differential equations, are subject to approximation and roundoff error. The larger the model description, the larger the total propagated error becomes for a given level of precision; to keep the level of error constant at a growing model size, the precision level must go up as a function of model size to a point at which this level of precision in combination with the limitations of the available hardware make use of a model impractical.
resources available for both detailed, timecourse in vivo concentration studies, and for the computational effort needed, pharmacokinetic investigators traditionally described the pharmacokinetics of a compound with data-based compartmental models-they generally measure the timecourse of the compound's concentration in a central compartment, normally blood, hypothesize a number of peripheral compartments of unknown size and chemical disposition, and fit an n-exponential model to the blood concentration versus time data, with n being the number of hypothesized compartments (14) .
Although this approach generally works well if one has the data needed to fit the model to, some researchers clearly were dissatisfied with the apparent physiological meaninglessness of the compartments and compound rate constants that constituted the n-exponential model. As early as 1937 Teorell (15, 16) (24) , Overton (25) A number of rationalizations have been given for this basic QSAR equation, all of which explicitly or implicitly rely on the notions of linear free energy relationships. We will use the one given by Hermens (28) because we believe it to be one of the most illustrative rationalizations. Consider that the activity of a biologically active molecule can be described as being dependent on a) the probability Pr, that a molecule reaches its (proposed) target site; b) the probability Pr2 that said molecule will successfully interact with this target; c) the dose, or external concentration C.
If we then assume that at a particular effect level the number of molecular events that has occurred C, is constant, we can easily see that: ct = c * Pr, * Pr2 * C= constant which, when log-transformed, becomes: log(1/C) = c+log Pr, +log Pr2.
Assuming then, without elaboration, that the hydrophobicity term (log K0W) from the Hansch equation, being a partition coefficient, is a good indicator of log Pr1, the probability of a chemical reaching a normally lipophilic site, and that the electronic and steric terms correlate to log Pr2, the actual interaction with the target site, for a set of congeneric molecules, the rationale behind the Hansch equation is clear.
Although QSAR analysis has been used extensively in the pharmaceutical field in the last 30 (37) . This is disfinding some relevant similarity that allows cussed further in the section "Two General the grouping of certain chemicals. For Cases." The scheme is then adjusted to example, in a mixture of eight chemicals limit the error as deemed necessary by the (A1, A2, A3, B1, B2, C1, C2, C3), imagine particular situation. The ideal situation that all of the As behave in a similar manner would be one of invariant response, i.e., in the process of interest, and the same fol-one in which the behavior of the system is lows for the Bs and the Cs. Then the eight not changed as the concentration ratio of chemicals could be grouped into three new chemicals within a given pseudocomponent pseudocomponents A, B, and C, so that the is changed. If all the chemicals in a pseudomixture can be considered to contain only component behaved in exactly the same three relevant chemicals (Figure 2) . manner, this would be the case; however, How the chemicals are lumped depends this situation rarely if ever occurs. on the behavior of the chemicals being Depending on the characteristics of the studied. In petroleum production processes system of interest, different methods of where cracking or breaking apart the large lumping may be used. Some of these are molecules and subsequent distillation are * A system can be described as either perthe most important issues, the molecular fectly or imperfectly lumpable. Other matrix manipulations take off from this point, and the papers by Wei and Kuo (38) and Kuo and Wei (37) illustrate other valid mathematics that apply to this example. Even from the limited mathematics presented here, it is evident that much has been gained by lumping. Originally, three different species had to be considered, along with the three reversible reactions that connected them. However, with the new pseudocomponents, only two species have to be considered, and now there is only one reversible reaction. Thus, from lumping, the matrices to be manipulated are considerably smaller and less subsequent computation will be required. Although this was a very simple example, it is apparent that with larger systems (those with five or ten or hundreds of components) the simplification could be immense.
A real-world example of such a welldefined lumping system is the Mobil 10-lump model, which was developed for catalytic cracking processes in the petroleum industry. This model is illustrated in Figure 4 .
In this model, the many petroleum compounds involved have been lumped into ten groups according to similarities in molecular structure and boiling point. Catalytic cracking is the decomposition of larger molecules into smaller molecules to achieve a more useful product, gasoline. However, only a fraction of these smaller molecules comprises the gasoline lump; those molecules even smaller than those in gasoline are grouped in the C lump. Average reaction kinetics have been determined for each of the reaction arrows shown in the diagram, so this system can be mathematically described in a manner similar to the matrix example described previously (13) .
The Mobil 10-lump scheme has been shown in the petroleum industry to be the most effective for the situation in which it is used, but, of course, an infinite number of possible schemes exist in theory. The key to lumping is to choose the lumping scheme that provides simplicity while maintaining a level of accuracy deemed necessary for the particular situation. For systems that fall into case 1, the well-defined case, there exists a mathematical means of determining the error introduced as additional groups are lumped together. Known as cluster analysis, this method is based on a set of statistical equations (13) . The error introduced with each additional reduction in system complexity (i.e., in going from 10 to 9 to 8 to 7 lumps) can be calculated, and the point at which the error exceeds an arbitrary acceptable level can be determined.
Systems for which most or all of the relevant properties are unknown ( Figure 5 ).
This improper lumping approach is also illustrated in Figure 6 as a very general compartmental diagram. Scheme 1, the pharmacokinetic scheme (which lumps those chemicals with similar pharmacokinetic fate), is designated by the solid arrows, and scheme 2, the dynamic scheme (which lumps those chemicals with similar A partial compositional breakdown of JP-5 is also available (46) . This describes about 36% of the composition ofJP-5 on a weight basis. This partial composition information can be used to estimate a chemical profile for JP-5 as a whole. See Table 1 for an overview of the known composition of JP-5. Figure 7 shows the distribution of mole fractions over log Kow windows based on the composition presented in Table 1 (light bars) and based on a hypothetical composition assuming that the unaccounted for compounds follow hydrophobicity profiles similar to that of the known compounds.
Systems To Be Modeled
Since JP-5 can be both a potential human health hazard (as in acute or chronic exposure of petroleum industry workers, fuel and airplane technicians, and aviators to jet fuel fumes or liquid present in their normal working environment (47, 45, 48) , as well as members of the general public following major spills, from continuous leaks or evaporative loss from contaminated sites), and an environmental health hazard (as air, water, or soil pollutant), it should be decided beforehand what biological system will be modeled and why.
Since it is more likely that JP-5 poses a health threat to workers who are occupationally exposed to it than that JP-5 will feature in a major environmental contamination, it appears that modeling human health effects would be the most appropriate action. If so, it can safely be assumed that human exposure will in most instances be inhalatory in Log Kow windows Figure 7 . Distribution of tentative JP-5 mole fractions over 1 log unit log K0, windows from 3 to 10. Light-colored bars are for percentages based on the fact that the JP-5 composition on which this exercise was based represented some 36% of its total mass; dark-colored bars are based on the assumption that the missing 64% is proportionally distributed over the recognized windows. Finally, effect parameters are needed to model specific toxicological end-points such as reactivity parameters for olefins that might be present in JP-5 and carcinogenicity parameters for possible residual PAHs.
Known Toxicological Effect ofJP-5 Expected but not Substantiated Effects.
Some research has been done on the possible toxicological effects of human and animal exposure to JP-5; human exposure has been focused mainly on inhalatory effects from JP-5 vapors, whereas animal studies (rats and mice) have been performed for inhalatory exposure as well as gavage dosing, dermal application, and intravenous administration (48) . The main conclusions that can be drawn from the results presented for these studies are as follows:
According to a mouse dermal application study (49) as well as a Salmonella typhimurium mutagenicity test (49) , JP-5 seems to be noncarcinogenic. This is somewhat surprising given the fact that a similar diesel fuel marine (DFM) is carcinogenic. The difference might be that, unlike DFM, JP-5 contains almost no polycyclic aromatic hydrocarbons (PAHs) (48) .
JP-5 and other kerosene products have an animal-specific renal toxicity to the male rat. Since this effect is directed to a unique rat protein, namely a2)i-globulin, which is pheromone-related, it is highly unlikely that JP-5 will exhibit such renal toxicity to species other than rat, induding humans (50, 44) .
Although not reported, toxic effects could in principle be expected from the known additives to JP-5, since all additives are known toxicants (42, 49, 48) . It should be noted here that the additives are present in very small quantities and that they are Environmental Health Perspectives * Vol 105, Supplement 1 * February 1997 l-I all highly nonvolatile. It therefore seems highly unlikely that effects would be seen after inhalation exposure to JP-5 vapors. Exposure to these additives is to be anticipated after transdermal or oral exposition, but so far no indication for the subsequent occurrence of toxic effects has been found in gavage or dermal application animal studies (48, 44) .
Target Organ Effects. Studies of JP-5 target organ effects have included the hematopoietic system. In a series of studies conducted at Wright-Patterson Air Force Base, Gaworski, MacEwen, Vernot, and co-workers exposed beagle dogs, F344 rats, and C57BL/6 mice for 90 days to JP-5 fuel vapors from either petroleum or shale oil sources [summarized in Gaworksi et al. (51) and MacEwen and Vernot (52)]. Hematocrit, hemoglobin, total erythrocytes, total leukocytes, differential counts, mean corpuscular volume, and mean corpuscular hemoglobin concentrations were determined. Beagle dog blood parameters remained within normal limits, although a slight erythrocyte osmotic fragility was observed after 90 days exposure at 750 mg m-3. No other significant changes were observed. Some fluctuations of erythrocyte levels were observed in rats, accompanied by slight changes in hematocrit and hemoglobin. No hematological effects were observed in C57BL/6 mice. Pathological studies of F344 rats and C57BL/6 mice showed no dose-related increases in leukemia in rats and no significant exposure-related effects in mice.
Liver toxicity of JP-5 has been studied in experimental rodents. Parker et al. (53) administered oral doses of JP-5 to male Sprague-Dawley rats and observed an oral LD50 of > 60 ml kg-'. Animals that died during the 40-day holding period had swollen, mottled livers and histopathologic evaluation of the survivors indicated hepatic periportal fatty changes. Similar studies using single oral doses of JP-5 followed by sacrifices over the next three days showed a clear pattern of liver injury accompanied by increased serum lactate dehydrogenase, glutamic-transaminase, and glutamic-pyruvate transaminase levels (53, 44, 54) . Inhalation exposures of beagle dogs, F344 rats, and C57BL/6 mice were conducted as part of the Wright-Patterson studies (55) . Immediately after exposure ended, the dogs exhibited diffuse mild swellings and clouding of hepatocytes which later were described as containing excess glycogen. Beagle dog exposures to 750 mg m-3 resulted in increased liver weights, increased liver/body weight ratios, and decreased glutamic-pyruvate transaminase levels. Rats showed no histopathology or serum enzyme changes immediately after exposure, but after 19 to 21 months there was mild hepatic hyperplasia. Exposed female mice in the same studies showed focal fatty changes in hepatocytes that stained positive for fat and mild diffuse cytoplasmic vacuolization that was negative for fat and glycogen only in the 750 mg m-3 exposure group. These changes resolved by 19 to 21 months post-exposure. In a study involving intermittent exposures (6 hr/day, 5 days/week for 6 weeks) of rats to 1 100 or 1600 mg m-3 of JP-5, Bogo et al. (54) reported no adverse effects in the liver and no change in serum enzyme levels.
Central nervous system (CNS) toxicity, generally classified under narcosis or general anaesthesia, is common to all volatile hydrocarbons (56, 57) and is similar to (or the same as) the narcosis effects of, for example, diethyl ether, nitrous oxide, or halothanes (58) . For example, Davies (59) described an incident in which a jet pilot was exposed to JP-4 vapors from a leaking fuel line during take off. He reported feeling groggy and weak and landed immediately. He exhibited a staggering gait, slurred speech, and signs of early anesthesia that were confirmed on physical examination. The pilot reported that he did not feel normal 36 hr after the event but appeared in good condition during the next few days and upon reexamination 5 months later. Estimated exposure concentration was 24,000 to 56,000 mg m-3 for a period of approximately 20 min.
It is assumed that this toxic effect is not compound-specific and is linked to the dissolution of the xenobiotic molecules in the cell membrane of (a.o.) nerve cells, thereby disrupting their normal operation and leading to depressed nerve cell action. There is a direct connection between a compound's hydrophobicity (expressed as its log Kow) and its efficacy as a general anesthetic (58) . The achievable depth of anesthesia is related to the minimum alveolar concentration necessary to produce anesthesia. The rate of anaesthetic onset is related to the blood/gas partition coefficient; for low ratios, onset is rapid and for high ratios onset is slow.
Chronic effects, following either prolonged (semi)continuous exposure to low or intermediate doses (concentrations) of JP-5 or acute exposure to extremely high concentrations, can tentatively be classified as Psycho-organic Solvent Syndrome (60), a condition characterized by general feelings of depression and inadequacy in the early stages and by concentration problems, loss of memory, impairment of mental abilities, and possibly dementia on prolonged exposure (several years or more). This condition seems to be slowly reversible in the initial (depression-like) stages but is only partly or nonreversible after onset of the more serious symptoms. The causative mechanism of this toxicological syndrome is not known, but one suggestion is that it might be linked to progressive demyelinization of nerve cell axons caused by the exposure to solvents. This effect might then also be linked to a compound's hydrophobicity, indicating its solvation potential to fatty molecules. However, attribution of a chronic neurological syndrome to solvents or other organic chemical exposures has been controversial (61) .
Data on chronic human exposure to jet fuels is limited. Knave and co-workers reported on two groups of aircraft factory workers exposed to jet fuels in the course of their daily activities (62) (63) (64) (65) (66) . No controls were available for this study. Reported symptoms of exposure included dizziness, headache, nausea, palpitations, and feeling of pressure on the chest during acute exposures at work. Chronic symptoms included neurasthenia, psychasthenia, and symptoms indicative of polyneuropathy. Clinical evaluation of nerve conduction velocity and vibration threshold revealed no remarkable findings. However, analysis of these exposed workers and reference groups by the authors led them to conclude that the jet fuelexposed workers demonstrated a higher than expected prevalence of these symptoms. In a study designed to obtain more information on chronic neurological effects of jet fuels, Knave et Compound-specific approaches. If a compound-specific approach is preferred, JP-5 samples could be characterized using gas chromatography (GC) or gas chromatography-mass spectography (GC-MS) techniques, and the major components, up to a total w/w percentage of ideally 60 to 95%, identified and quantified. Log Kow values could then be either retrieved or generated for each of the identified components and the behaviour of JP-5 modeled as the joint (additive) action of all these individual components.
Alternatively, the approach mentioned in the Composition section, where JP-5 is described based on partial composition data, assuming the unknown fraction is similar in hydrophobicity profile to the known fraction, could be used to generate a compound-specific partition coefficient profile ofJP-5.
Additionally, knowledge or partial knowledge about the composition of would allow a functional lumping analysis, based on the hydrocarbon block method (69) (70) (71) , thereby greatly reducing the complexity of the subsequent modeling process (not unlike when using the surrogate components). The hydrocarbon block method is an approach in which based on knowledge of the (preferably exact) composition of a hydrocarbon mixture, one assigns each constituent to a certain pseudocompound based on its hydrophobicity (log K,). The (45) showed that the average molar mass of the liquid bulk of a JP-4 sample was 125 g, whereas the molar mass of the associated headspace vapor was 85 g. Note that the observed difference will be less pronounced for JP-5 because of its narrower overall boiling range with a higher low end. This specific problem could be tackled in two ways. First, for any of the analytical methods described above in the Partition Coefficients section, the sample to be analyzed could be taken from a controlled JP-5 headspace instead of from JP-5 bulk liquid. Alternatively, vapor pressures or Henry's law constants could be predicted from hydrophobicity profiles as generated by the Verbruggen method (68 Moreover, it has been and can be shown that even in mixtures of explicitly nonadditive (either synergistic, potentiating, or antagonistic) chemicals, the overall effect of a mixture tends toward an additive, narcotic limit for n approaching infinity, with n being the number of compounds in a mixture, provided the mixture has approximately equal distribution of compound mole fractions [(72) , see also Berenbaum (40) ]. This phenomenon is ascribed to the notion that for such a mixture individual compounds or groups of compounds acting on the same receptor or by the same mechanism, are generally present at concentrations below their pharmacologic/toxicologic threshold level. The one thing they then have in common is their ability to partition into membranes and elicit narcosis; since all compounds in principle have this ability, and simple narcosis is an additive phenomenon based on molar units, the associated joint toxic action is additive.
Conclusions
Over the last decades, a number of techniques have been developed, and a number of advances have been made in the fields of chemical, toxicological, and computational sciences that when combined offer for the first time in the study of the toxicology of chemical mixtures the possibility of actually predicting some aspects of the toxicity of said mixtures. In this paper we have introduced and briefly described three techniques we think will form the cornerstones of predictive toxicology for (complex) chemical mixtures in the near future. These three techniques are: QSAR analysis, which can be used to predict needed physicochemical and toxicological parameters for unknown compounds or for surrogate compounds; lumping analysis, which can drastically reduce the complexity of the description of a mixture while reporting the error introduced by a particular level of simplification so the artificially introduced error can be kept within reasonable limits; and PBPK/PD modeling, which can be used to describe the toxicokinetics (and possibly the toxicodynamics) of an ensemble of compounds or lumped pseudocompounds, including possible interaction effects. In combination, these three tools can be used to predict target organ/site levels of individual compounds or the entire mixture from exposure data-or conversely, they can be used to set safe exposure levels given threshold target site doses or dosetime combinations. This enables one to deal with the predicted toxicity of complex mixtures in a more integrated way than just focusing on one or two major components; moreover, it offers an approach to predict at least some toxicological aspects of unknown, or partially known, or variable mixtures.
We have illustrated this approach by describing how it can be applied to the integrated risk assessment ofa navy jet fuel, JP-5, a complex mixture of mainly hydrocarbons. We define G(k) as G(k)lCso G(oo)=1. It can be seen that C(t) is the Laplace-Stieltjes transform of the mixing discrete distribution. This distribution summarizes the between-component variability in the current simple system. Now consider replacing the above system with a single-component (S-C) system: C(t;K) = Celt (A. 4) The problem is to determine the (single) summarizing rate parameter, K. We do so by assigning a penalty for lack-of-fit of the S-C representation to the true function. Notice that, for any K, this considers an error or fit-discrepancy at every t, namely C(t;K)-C(t) and squares it; then each such squared error is multiplied by a discount factor, e-Ot that, for6 >0, weights the early discrepancies more extensively than those occurring later in time. Finally, all such discounted squared discrepancies are added (integrated) to obtain the fit score, S1(K; 6); which can be solved for K. Example 2: Reverse-Exponential Discounting. Suppose we want a weight scheme that concentrates on and attempts to minimize all errors that occur at large times. One way is to replace e-Ot in (A. (A.24)
Solve for ic. Other weightings are also possible.
